Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Who Its For : Suitable for adults with obesity or weight-related health conditions
That enrolment breakdown is worth stating carefully, because the trials own abstract phrases it in a way that is easy to misread: it says 706 participants were assigned to cagrilintide 0.34.5 mg (100102 per dose group), 99 to liraglutide 3.0 mg, and 101 to placebo. Read literally, that would put the trial at over 900 people
This knowledge empowers patients to report any changes promptly and participate actively in their treatment plan
S2CID 45739342
US$ 22.76
US$ 28.75
US$ 26.97
US$ 24.33
US$ 25.93
US$ 26.52
US$ 23.26
US$ 27.45
US$ 21.23
